What Researchers Did
Researchers reported on a case of a four-year-old boy with chronic granulomatous disease and refractory osteomyelitis treated with additional hyperbaric oxygen therapy.
What They Found
They found that hyperbaric oxygen therapy was well tolerated in the four-year-old boy with chronic granulomatous disease and osteomyelitis. This additional treatment led to the resolution of the osteomyelitis, which had previously been refractory to intravenous antibiotics.
What This Means for Canadian Patients
For Canadian patients with chronic granulomatous disease experiencing osteomyelitis that does not respond to standard antibiotics, hyperbaric oxygen therapy might be a potential additional treatment option. This approach could offer a new avenue for managing severe infections in this vulnerable patient population.
Canadian Relevance
This study has no direct Canadian connection as it is a case report from Germany.
Study Limitations
As a single case report, the findings cannot be generalized and require further investigation in larger studies.